SCHEMBL1899016

SCHEMBL1899016

CCCCCCCCOS(C)(=O)=O

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.75
KDM4E B2RXH2 1/20 0.75
USP2 O75604 1/20 0.75
ALDH1A1 P00352 1/20 0.75
LMNA P02545 1/20 0.75
MMP9 P14780 1/20 0.75
ALOX15 P16050 1/20 0.75
CA1 P00915 15/20 0.64
CA2 P00918 15/20 0.64
CA9 Q16790 13/20 0.64
CA12 O43570 4/20 0.64
CA7 P43166 4/20 0.64
CA14 Q9ULX7 4/20 0.64
CA3 P07451 3/20 0.64
CA4 P22748 3/20 0.64
CA6 P23280 3/20 0.64
CA5A P35218 3/20 0.64
CA5B Q9Y2D0 3/20 0.64
RECQL P46063 2/20 0.61
GLA P06280 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11748392 1.00 TSHR (0.75) TSHRKDM4EUSP2ALDH1A1LMNA
SCHEMBL5605250 1.00 TSHR (0.75) TSHRKDM4EUSP2ALDH1A1LMNA
Methanesulfonic Acid Dodecyl Ester SCHEMBL2223590 1.00 TSHR (0.75) TSHRKDM4EUSP2ALDH1A1LMNA
SCHEMBL7726676 1.00 TSHR (0.75) TSHRKDM4EUSP2ALDH1A1LMNA
SCHEMBL11225069 1.00 TSHR (0.75) TSHRKDM4EUSP2ALDH1A1LMNA
SCHEMBL1443722 1.00 TSHR (0.75) TSHRKDM4EUSP2ALDH1A1LMNA
SCHEMBL908020 1.00 TSHR (0.75) TSHRKDM4EUSP2ALDH1A1LMNA
SCHEMBL3092383 1.00 TSHR (0.75) TSHRKDM4EUSP2ALDH1A1LMNA
SCHEMBL140845 1.00 TSHR (0.75) TSHRKDM4EUSP2ALDH1A1LMNA
SCHEMBL11236129 1.00 TSHR (0.75) TSHRKDM4EUSP2ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 148 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109400476-A A kind of preparation method of long-chain ester 华东理工大学 2019-03-01 CN claimed
CN-105287604-A A pharmaceutical combination comprising an IBAT inhibitor and a bile acid binder ALBIREO AB 2016-02-03 CN claimed
CN-101056848-A Process for preparing polyisocyanates BASF AG (DE) 2007-10-17 CN claimed
CN-1978431-A Ionic liquid using quaternary ammonium caprolactam as cation and its preparing method LANZHOU CHEM PHYS INST (CN) 2007-06-13 CN claimed
EP-0707094-B1 Process for preparing perfluoroalkanesulfonyl fluorides MINNESOTA MINING & MFG (US) 1998-07-22 EP claimed
EP-0707094-A1 Process for preparing perfluoroalkanesulfonyl fluorides MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1996-04-17 EP claimed
US-5486271-A Process for preparing perfluoroalkanesulfonyl fluorides MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1996-01-23 US claimed
US-12603388-B2 Single-ion electrolytes for solid-state alkaline batteries THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2026-04-14 US disclosed
US-20260094934-A1 SINGLE-ION ELECTROLYTES FOR SOLID-STATE ALKALINE BATTERIES THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2026-04-02 US disclosed
US-20240376256-A1 ORGANIC BINDER, COMPOSITION FOR PRODUCING INORGANIC MATERIAL MOLDED ARTICLE, GREEN BODY, DEGREASED BODY, INORGANIC MATERIAL MOLDED ARTICLE, AND METHOD OF PRODUCING INORGANIC MATERIAL MOLDED ARTICLE KUREHA CORPORATION (JP) 2024-11-14 US disclosed
CN-115551862-B Macrocyclic inhibitors of peptidyl arginine deiminase 吉利德科学公司 2024-04-12 CN disclosed
CN-117529377-A Organic binder, composition for producing inorganic material molded body, green body, degreased body, inorganic material molded body, and method for producing inorganic material molded body 株式会社吴羽 2024-02-06 CN disclosed
WO-2023151635-A1 COMPOUND BASED ON QUINAZOLINE-SUBSTITUTED GLUTARIMIDE SKELETON AND USE THEREOF 标新生物医药科技(上海)有限公司 2023-08-17 WO disclosed
WO-1986004893-A1 PROCESS FOR THE PREPARATION OF ALKYL FLUORIDES ZAMBON S.P.A. (IT) 1986-08-28 WO disclosed
US-4608386-A ASTHMA E. R. SQUIBB & SONS, INC. (US) 1986-08-26 US disclosed
US-4595692-A 7-thiabicycloheptane substituted ethers E. R. SQUIBB & SONS, INC. (US) 1986-06-17 US disclosed
US-4582854-A BRONCHODILATOR, ANTIINFLAMMATORY AGENT, ANALGESIC E. R. SQUIBB & SONS, INC. (US) 1986-04-15 US disclosed
US-4575512-A THROMBOXANE SYNTHETASE INHIBITORS E. R. SQUIBB & SONS, INC. (US) 1986-03-11 US disclosed
US-4523208-A SULFONIC ACID ESTER AS ACTIVATOR BASF AKTIENGESELLSCHAFT (DE) 1985-06-11 US disclosed
US-3989816-A PENETRATION OF SKINS OR MEMBRANES NELSON RESEARCH & DEVELOPMENT COMPANY (US) 1976-11-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260094934-A1 SINGLE-ION ELECTROLYTES FOR SOLID-STATE ALKALINE BATTERIES CACNA2D1, CACNA2D2, CACNA2D4 TSHR 3969/4885KDM4E 1531/4885USP2 4741/4885
US-12603388-B2 Single-ion electrolytes for solid-state alkaline batteries CACNA2D1, CACNA2D2, CACNA2D4 TSHR 3969/4885KDM4E 1531/4885USP2 4741/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.